A61K 2039/517
Plant cells
Official title: {Plant cells}
A61K2039/517 (Plant cells) appears on 37 US grants and 98 published applications in this corpus.
Search patents in A61K- Granted patents
- 37
- Published applications
- 98
- Assignees
- 59
- Inventors
- 199
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 1 |
| 2005 | 1 | 3 |
| 2006 | 0 | 3 |
| 2007 | 0 | 4 |
| 2008 | 2 | 6 |
| 2009 | 1 | 6 |
| 2010 | 1 | 10 |
| 2011 | 3 | 13 |
| 2012 | 5 | 4 |
| 2013 | 1 | 7 |
| 2014 | 1 | 10 |
| 2015 | 2 | 4 |
| 2016 | 5 | 2 |
| 2017 | 2 | 4 |
| 2018 | 3 | 2 |
| 2019 | 2 | 1 |
| 2020 | 1 | 3 |
| 2021 | 2 | 1 |
| 2022 | 0 | 4 |
| 2023 | 2 | 2 |
| 2024 | 0 | 3 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Arthrospira platensis non-parenteral therapeutic delivery platform23 Dec 2025US 12,503,682 B2Lumen Bioscience, Inc.
- Method of preparing plant-derived proteins5 Dec 2023US 11,833,200 B2Medicago Inc.
- Method of preparing plant-derived VLPs28 Nov 2023US 11,826,419 B2Medicago Inc.
- Plant-produced vaccine comprising an AG2 polypeptide from coccidioides21 Sep 2021US 11,124,799 B2Applied Biotechnology Institute, Inc.
- Methods and compositions to increase immune response to vaccines17 Aug 2021US 11,090,380 B2Applied Biotechnology Institute, Inc.
- Arthrospira platensis non-parenteral therapeutic delivery platform23 Apr 2026US 2026/0109941 A1Lumen Bioscience, Inc.
- Expression of eimeria sequences in plants and plant produced vaccine for same27 Mar 2025US 2025/0099563 A1Mazen Animal Health Inc.
- Expression of eimeria sequences in plants and plant produced vaccine for same19 Dec 2024US 2024/0417744 A1Mazen Animal Health Inc.
- Constructs comprising single domain vhh antibodies against sars cov-29 May 2024US 2024/0150440 A1Lumen Bioscience, Inc.
- Nkg2a-targeting antibody and use thereof8 Feb 2024US 2024/0043532 A1Bioheng Therapeutics Limited
Most cited
By later US patents
- Transgenic algae for delivering antigens to an animal27US 7,410,637 B2Phycotransgenics L.L.C. · 2008
- Influenza antigens, vaccine compositions, and related methods11US 8,124,103 B2Fraunhofer USA, Inc. · 2012
- Expression of protective antigens in transgenic chloroplasts7US 7,354,760 B2University of Central Florida Research Foundation, Inc. · 2008
- Influenza virus immunizing epitope6US 9,546,375 B2Medicago Inc. · 2017
- Influenza virus-like particles (VLPS) comprising hemagglutinin5US 9,492,528 B2Medicago Inc. · 2016